skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:015044/0873   Pages: 7
Recorded: 08/06/2004
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 81
1
Patent #:
Issue Dt:
12/14/1993
Application #:
07680808
Filing Dt:
03/12/1991
Title:
ANTI-IDIOTYPE ANTIBODIES TO HUMAN MELANOMA-ASSOCIATED PROTEOGLYCAN ANTIGEN
2
Patent #:
Issue Dt:
12/17/1996
Application #:
07919787
Filing Dt:
07/24/1992
Title:
INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
3
Patent #:
Issue Dt:
07/15/1997
Application #:
08147696
Filing Dt:
11/03/1993
Title:
IMPAIRED DOMINANT SELECTABLE MARKER SEQUENCE AND INTRONIC INSERTION STRATEGIES FOR ENHANCEMENT OF EXPRESSION OF GENE PRODUCT AND EXPRESSION VECTOR SYSTEMS COMPRISING SAME
4
Patent #:
Issue Dt:
01/20/1998
Application #:
08351001
Filing Dt:
12/07/1994
Title:
INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
5
Patent #:
Issue Dt:
08/19/1997
Application #:
08379072
Filing Dt:
01/25/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
6
Patent #:
Issue Dt:
08/07/2001
Application #:
08449728
Filing Dt:
05/24/1995
Title:
INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
7
Patent #:
Issue Dt:
12/09/1997
Application #:
08472311
Filing Dt:
06/07/1995
Title:
INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
8
Patent #:
Issue Dt:
05/26/1998
Application #:
08476237
Filing Dt:
06/07/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
9
Patent #:
Issue Dt:
05/12/1998
Application #:
08476349
Filing Dt:
06/07/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
10
Patent #:
Issue Dt:
10/28/1997
Application #:
08478039
Filing Dt:
06/07/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
11
Patent #:
Issue Dt:
12/02/1997
Application #:
08481869
Filing Dt:
06/07/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
12
Patent #:
Issue Dt:
03/31/1998
Application #:
08484334
Filing Dt:
06/07/1995
Title:
IMPAIRED DOMINANT SELECTABLE MARKER SEQUENCE AND INTRONIC INSERTION STRATEGIES FOR ENHANCEMENT OF EXPRESSION OF GENE PRODUCT AND EXPRESSION VECTOR SYSTEMS COMPRISING SAME
13
Patent #:
Issue Dt:
09/05/2000
Application #:
08487550
Filing Dt:
06/07/1995
Title:
HUMAN B7.1-SPECIFIC PRIMATIZED ANTIBODIES AND TRANSFECTOMAS EXPRESSING SAID ANTIBODIES
14
Patent #:
Issue Dt:
09/22/1998
Application #:
08488376
Filing Dt:
06/07/1995
Title:
NEUTRALIZING HIGH AFFINITY HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO RSV F-PROTEIN AND METHODS FOR THEIR MANUFACTURE AND THERAPEUTIC USE THEREOF
15
Patent #:
Issue Dt:
10/24/2000
Application #:
08523894
Filing Dt:
09/06/1995
Title:
RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY
16
Patent #:
Issue Dt:
12/14/1999
Application #:
08554840
Filing Dt:
11/07/1995
Title:
HUMANIZED ANTIBODIES TO HUMAN GP39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
17
Patent #:
Issue Dt:
11/24/1998
Application #:
08634223
Filing Dt:
04/18/1996
Title:
NEUTRALIZING HIGH AFFINITY HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO RSV F-PROTEIN AND METHODS FOR THEIR MANUFACTURE AND THERAPEUTIC USE THEREOF
18
Patent #:
Issue Dt:
02/02/1999
Application #:
08634224
Filing Dt:
04/18/1996
Title:
NEUTRALIZING HIGH AFFINITY HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO RSV F-PROTEIN AND METHODS FOR THEIR MANUFACTURE AND THERAPEUTIC USE THEREOF
19
Patent #:
Issue Dt:
08/17/1999
Application #:
08634400
Filing Dt:
04/18/1996
Title:
NEUTRALIZING HIGH AFFINITY HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO RSV F-PROTEIN AND METHODS FOR THEIR MANUFACTURE AND THERAPEUTIC USE THEREOF
20
Patent #:
Issue Dt:
09/21/1999
Application #:
08635878
Filing Dt:
04/18/1996
Title:
NEUTRALIZING HIGH AFFINITY HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO RSV F-PROTEIN AND METHODS FOR THEIR MANUFACTURE AND THERAPEUTIC USE THEREOF
21
Patent #:
Issue Dt:
11/03/1998
Application #:
08819866
Filing Dt:
03/14/1997
Title:
NOVEL METHOD FOR INTEGRATING GENES AT SPECIFIC SITES IN MAMMALIAN CELLS VIA HOMOLOGOUS RECOMBINATION AND VECTORS FOR ACCOMPLISHING THE SAME
22
Patent #:
Issue Dt:
08/27/2002
Application #:
08925339
Filing Dt:
09/08/1997
Title:
METHODS OF TREATING AUTOIMMUNE DISEASES WITH GP39-SPECIFIC ANTIBODIES
23
Patent #:
Issue Dt:
01/25/2000
Application #:
09013092
Filing Dt:
01/26/1998
Title:
IMPAIRED DOMINANT SELECTABLE MARKER SEQUENCE AND INTRONIC INSERTION STRATEGIES FOR ENHANCEMENT OF EXPRESSION OF GENE PRODUCT AND EXPRESSION VECTOR SYSTEMS COMPRISING SAME
24
Patent #:
Issue Dt:
12/07/1999
Application #:
09023715
Filing Dt:
02/13/1998
Title:
METHOD FOR INTEGRATING GENES AT SPECIFIC SITES IN MAMMALIAN CELLS VIA HOMOLOGOUS RECOMBINATION AND VECTORS FOR ACCOMPLISHING THE SAME
25
Patent #:
Issue Dt:
03/06/2001
Application #:
09024220
Filing Dt:
02/17/1998
Title:
INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
26
Patent #:
Issue Dt:
05/24/2005
Application #:
09238741
Filing Dt:
01/28/1999
Title:
PRODUCTION OF TETRAVALENT ANTIBODIES
27
Patent #:
NONE
Issue Dt:
Application #:
09259337
Filing Dt:
03/01/1999
Publication #:
Pub Dt:
08/01/2002
Title:
RADIOLABELING KIT AND BINDING ASSAY
28
Patent #:
Issue Dt:
10/09/2001
Application #:
09259347
Filing Dt:
03/01/1999
Title:
ELECTROCHEMILUMINESCENT ASSAYS FOR EUKARYOTIC CELLS
29
Patent #:
Issue Dt:
03/27/2001
Application #:
09261207
Filing Dt:
03/03/1999
Title:
REGIOSELECTIVE SYNTHESIS OF DTPA DERIVATIVES
30
Patent #:
Issue Dt:
12/12/2000
Application #:
09280999
Filing Dt:
03/30/1999
Title:
IMPAIRED DOMINANT SELECTABLE MARKER SEQUENCE AND INTRONIC INSERTION STRATEGIES FOR ENHANCEMENT OF EXPRESSION OF GENE PRODUCT AND EXPESSION VECTOR SYSTEMS COMPRISING SAME
31
Patent #:
Issue Dt:
01/14/2003
Application #:
09332595
Filing Dt:
06/14/1999
Title:
HUMANIZED ANTIBODIES OF HUMAN GP39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
32
Patent #:
Issue Dt:
07/02/2002
Application #:
09335697
Filing Dt:
06/18/1999
Publication #:
Pub Dt:
06/27/2002
Title:
NEUTRALIZING HIGH AFFINITY HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO RSV F-PROTEIN AND METHODS FOR THEIR MANUFACTURE AND THERAPUTIC USE THEREOF
33
Patent #:
Issue Dt:
07/02/2002
Application #:
09343485
Filing Dt:
06/30/1999
Title:
NOVEL METHOD FOR INTEGRATING GENES AT SPECIFIC SITES IN MAMMALIAN CELLS VIA HOMOLOGOUS RECOMBINATION AND VECTORS FOR ACCOMPLISHING THE SAME
34
Patent #:
Issue Dt:
03/23/2004
Application #:
09383916
Filing Dt:
08/26/1999
Title:
TREATMENT OF PSORIASIS USING ANTI-B7.1(CD80) ANTIBODIES
35
Patent #:
Issue Dt:
02/13/2007
Application #:
09576424
Filing Dt:
05/22/2000
Title:
TREATING INTESTINAL INFLAMMATION WITH ANTI-CD80 ANTIBODIES THAT DO NOT INHBIT CD80 BINDING TO CTLA-4
36
Patent #:
Issue Dt:
11/18/2008
Application #:
09612914
Filing Dt:
07/10/2000
Title:
RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY
37
Patent #:
Issue Dt:
09/17/2002
Application #:
09625856
Filing Dt:
07/26/2000
Title:
NEW CLINICAL PARAMETERS FOR DETERMINING HEMATOLOGIC TOXICITY PRIOR TO RADIOIMMUNOTHERAPHY
38
Patent #:
Issue Dt:
02/07/2006
Application #:
09628186
Filing Dt:
07/28/2000
Title:
KIT FOR RADIOLABELING LIGANDS WITH YTTRIUM-90
39
Patent #:
Issue Dt:
05/11/2004
Application #:
09740003
Filing Dt:
12/20/2000
Publication #:
Pub Dt:
04/04/2002
Title:
INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
40
Patent #:
Issue Dt:
05/17/2005
Application #:
09758173
Filing Dt:
01/12/2001
Publication #:
Pub Dt:
09/27/2001
Title:
METHODS FOR TREATING B CELL LYMPHOMA USING CD80-SPECIFIC ANTIBODIES
41
Patent #:
NONE
Issue Dt:
Application #:
09772938
Filing Dt:
01/31/2001
Publication #:
Pub Dt:
01/17/2002
Title:
Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
42
Patent #:
NONE
Issue Dt:
Application #:
09791551
Filing Dt:
02/26/2001
Publication #:
Pub Dt:
12/25/2003
Title:
Method for preparing anti-MIF antibodies
43
Patent #:
Issue Dt:
10/10/2006
Application #:
09798525
Filing Dt:
02/21/2001
Publication #:
Pub Dt:
04/18/2002
Title:
METHOD FOR PRODUCING HUMAN ANTIBODIES IN SCID MICE WHICH USES DENDRITIC CELLS PULSED WITH ANTIGEN-ANTIBODY COMPLEXES AND ANTIGEN-ANTIBODY COMPLEXES AS IMMUNIZING AGENTS
44
Patent #:
NONE
Issue Dt:
Application #:
09805217
Filing Dt:
03/14/2001
Publication #:
Pub Dt:
02/28/2002
Title:
Antibodies that bind phosphatidyl serine and a method of their use
45
Patent #:
Issue Dt:
05/24/2005
Application #:
09822672
Filing Dt:
04/02/2001
Publication #:
Pub Dt:
01/31/2002
Title:
COMBINED USE OF ANTI-CYTOKINE ANTIBODIES OR ANTAGONISTS AND ANTI-CD20 FOR TREATMENT OF B CELL LYMPHOMA
46
Patent #:
NONE
Issue Dt:
Application #:
09834933
Filing Dt:
04/16/2001
Publication #:
Pub Dt:
08/30/2001
Title:
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
47
Patent #:
NONE
Issue Dt:
Application #:
09840872
Filing Dt:
04/25/2001
Publication #:
Pub Dt:
01/24/2002
Title:
Intrathecal administration of rituximab for treatment of central nervous system lymphomas
48
Patent #:
NONE
Issue Dt:
Application #:
09850165
Filing Dt:
05/08/2001
Publication #:
Pub Dt:
10/17/2002
Title:
Recombinant antibodies for human therapy
49
Patent #:
NONE
Issue Dt:
Application #:
09853580
Filing Dt:
05/14/2001
Publication #:
Pub Dt:
08/30/2001
Title:
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
50
Patent #:
Issue Dt:
02/14/2006
Application #:
09853581
Filing Dt:
05/14/2001
Publication #:
Pub Dt:
09/06/2001
Title:
SYNERGISTIC COMPOSITION AND METHODS FOR TREATING NEOPLASTIC OR CANCEROUS GROWTHS AND FOR RESTORING OR BOOSTING HEMATOPOIESIS
51
Patent #:
NONE
Issue Dt:
Application #:
09855717
Filing Dt:
05/16/2001
Publication #:
Pub Dt:
03/07/2002
Title:
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
52
Patent #:
NONE
Issue Dt:
Application #:
09874141
Filing Dt:
06/06/2001
Publication #:
Pub Dt:
01/16/2003
Title:
Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
53
Patent #:
NONE
Issue Dt:
Application #:
09877065
Filing Dt:
06/11/2001
Publication #:
Pub Dt:
05/02/2002
Title:
Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
54
Patent #:
Issue Dt:
01/25/2005
Application #:
09883962
Filing Dt:
06/20/2001
Publication #:
Pub Dt:
04/04/2002
Title:
TREATMENT OF B-CELL ASSOCIATED DISEASES SUCH AS MALIGNANCES AND AUTOIMMUNE DISEASES USING A COLD ANTI-CD20 ANTIBODY/RADIOLABELED ANTI-CD22 ANTIBODY COMBINATION
55
Patent #:
NONE
Issue Dt:
Application #:
09954274
Filing Dt:
09/18/2001
Publication #:
Pub Dt:
05/16/2002
Title:
Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory antibody combination
56
Patent #:
NONE
Issue Dt:
Application #:
09971631
Filing Dt:
10/09/2001
Publication #:
Pub Dt:
02/20/2003
Title:
Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
57
Patent #:
NONE
Issue Dt:
Application #:
09982849
Filing Dt:
10/22/2001
Publication #:
Pub Dt:
09/12/2002
Title:
Variant IgG3 Rituxan and therapeutic use thereof
58
Patent #:
NONE
Issue Dt:
Application #:
09985646
Filing Dt:
11/05/2001
Publication #:
Pub Dt:
10/31/2002
Title:
Use of CD23 antagonists for the treatment of neoplastic disorders
59
Patent #:
NONE
Issue Dt:
Application #:
09986174
Filing Dt:
11/07/2001
Publication #:
Pub Dt:
12/19/2002
Title:
Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
60
Patent #:
Issue Dt:
01/15/2008
Application #:
10058069
Filing Dt:
01/29/2002
Publication #:
Pub Dt:
12/06/2007
Title:
TAG-72 SPECIFIC CH2 DOMAIN DELETED ANTIBODIES
61
Patent #:
Issue Dt:
12/26/2006
Application #:
10073138
Filing Dt:
02/13/2002
Publication #:
Pub Dt:
12/12/2002
Title:
TREATMENT OF B CELL LYMPHOMA USING ANTI-CD80 ANTIBODIES THAT DO NOT INHIBIT THE BINDING OF CD80 TO CTLA-4
62
Patent #:
NONE
Issue Dt:
Application #:
10096963
Filing Dt:
03/14/2002
Publication #:
Pub Dt:
09/25/2003
Title:
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
63
Patent #:
Issue Dt:
01/11/2005
Application #:
10109853
Filing Dt:
04/01/2002
Publication #:
Pub Dt:
12/19/2002
Title:
NOVEL METHOD FOR INTEGRATING GENES AT SPECIFIC SITES IN MAMMALIAN CELLS VIA HOMOLOGOUS RECOMBINATION AND VECTORS FOR ACCOMPLISHING THE SAME
64
Patent #:
NONE
Issue Dt:
Application #:
10113929
Filing Dt:
04/02/2002
Publication #:
Pub Dt:
01/02/2003
Title:
Recombinant antibodies coexpressed with GnTIII
65
Patent #:
Issue Dt:
07/11/2006
Application #:
10171680
Filing Dt:
06/17/2002
Publication #:
Pub Dt:
09/18/2003
Title:
HUMANIZED ANTIBODIES TO HUMAN GP39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
66
Patent #:
Issue Dt:
10/17/2006
Application #:
10171681
Filing Dt:
06/17/2002
Publication #:
Pub Dt:
09/11/2003
Title:
TREATING AUTOIMMUNE DISEASES WITH HUMANIZED ANTI-CD40L ANTIBODY
67
Patent #:
Issue Dt:
10/20/2009
Application #:
10191052
Filing Dt:
07/10/2002
Publication #:
Pub Dt:
04/03/2003
Title:
INHIBITION OF APOPTOSIS PROCESS AND IMPROVEMENT OF CELL PERFORMANCE
68
Patent #:
Issue Dt:
03/27/2007
Application #:
10195426
Filing Dt:
07/16/2002
Publication #:
Pub Dt:
11/13/2003
Title:
NEW CLINICAL PARAMETERS FOR DETERIMING HEMATOLOGIC TOXICITY PRIOR TO RADIOIMMUNOTHERAPY
69
Patent #:
Issue Dt:
03/04/2008
Application #:
10211357
Filing Dt:
08/05/2002
Publication #:
Pub Dt:
04/24/2003
Title:
RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY
70
Patent #:
NONE
Issue Dt:
Application #:
10241832
Filing Dt:
09/12/2002
Publication #:
Pub Dt:
11/13/2003
Title:
Use of CD23 antagonists for the treatment of neoplastic disorders
71
Patent #:
NONE
Issue Dt:
Application #:
10241836
Filing Dt:
09/12/2002
Publication #:
Pub Dt:
06/05/2003
Title:
Immunoregulatory antibodies and uses thereof
72
Patent #:
NONE
Issue Dt:
Application #:
10291532
Filing Dt:
11/12/2002
Publication #:
Pub Dt:
09/25/2003
Title:
Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies
73
Patent #:
NONE
Issue Dt:
Application #:
10295823
Filing Dt:
11/18/2002
Publication #:
Pub Dt:
08/21/2003
Title:
Polycistronic expression of antibodies
74
Patent #:
NONE
Issue Dt:
Application #:
10367978
Filing Dt:
02/19/2003
Publication #:
Pub Dt:
12/25/2003
Title:
Prostate specific genes and the use thereof in design or therapeutics
75
Patent #:
NONE
Issue Dt:
Application #:
10384356
Filing Dt:
03/10/2003
Publication #:
Pub Dt:
01/08/2004
Title:
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
76
Patent #:
Issue Dt:
05/22/2007
Application #:
10661086
Filing Dt:
09/12/2003
Publication #:
Pub Dt:
12/02/2004
Title:
METHOD OF PURIFYING POLYPEPTIDES BY SIMULATED MOVING BED CHROMATOGRAPHY
77
Patent #:
NONE
Issue Dt:
Application #:
10703669
Filing Dt:
11/10/2003
Publication #:
Pub Dt:
05/26/2005
Title:
Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination
78
Patent #:
NONE
Issue Dt:
Application #:
10743398
Filing Dt:
12/23/2003
Publication #:
Pub Dt:
10/07/2004
Title:
Induction of cytotoxic T-lymphocyte responses
79
Patent #:
NONE
Issue Dt:
Application #:
10743739
Filing Dt:
12/24/2003
Publication #:
Pub Dt:
07/15/2004
Title:
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
80
Patent #:
NONE
Issue Dt:
Application #:
10796158
Filing Dt:
03/10/2004
Publication #:
Pub Dt:
06/02/2005
Title:
Thiol-mediated drug attachment to targeting peptides
81
Patent #:
Issue Dt:
01/02/2007
Application #:
10871261
Filing Dt:
06/21/2004
Publication #:
Pub Dt:
02/17/2005
Title:
USE OF DEPTH FILTRATION IN SERIES WITH CONTINUOUS CENTRIFUGATION TO CLARIFY MAMMALIAN CELL CULTURES
Assignor
1
Exec Dt:
11/12/2003
Assignee
1
3030 CALLAN ROAD
SAN DIEGO, CALIFORNIA 92121
Correspondence name and address
PILLSBURY WINTHROP LLP
THOMAS A. CAWLEY, JR.
P.O. BOX 10500
INTELLECTUAL PROPERTY GROUP
MCLEAN, VA 22102

Search Results as of: 06/07/2024 09:23 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT